Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment

References

• Atiyeh BS, Gunn SW, Hayek SN. (2005). State of the art in burn treatment. World J Surg 29:131–48
   PubMed Web of Science ®Google Scholar
• Baddley JW, Winthrop KL, Patkar NM, et al. (2011). Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 17:1664–9
   PubMed Web of Science ®Google Scholar
• Barwicz J, Christian S, Gruda I. (1992). Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother 36:2310–15
   PubMed Web of Science ®Google Scholar
• Bauer AW, Kirby WM, Sherris JC, Turck M. (1996). Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–6
   Google Scholar
• Benedict S, Colagreco J. (1994). Fungal infections associated with malignancies, treatments and AIDS. Cancer Nurs 17:411–17
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Levitz SM. (2012). Tackling human fungal infections. Science 336:647
   PubMed Web of Science ®Google Scholar
• Butani D, Yewale C, Misra A. (2014). Amphotericin B topical microemulsion: formulation, characterization and evaluation. Colloids Surf B 116:351–8
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs liposomes. Biomaterials 21:1879–85
   PubMed Web of Science ®Google Scholar
• Draize J, Woodard G, Calvery H. (1944). Methods for the study of irritation and toxicity of substance applied to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
   Web of Science ®Google Scholar
• Dubey V, Mishra D, Nahar M, et al. (2010). Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine 6:590–6
   PubMed Web of Science ®Google Scholar
• El-On J, Jacobs GP, Witztum E, Greenblatt CL. (1984). Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. Antimicrob Agents Chemother 26:745–51
   PubMed Web of Science ®Google Scholar
• Fungal Research Trust. (n.d.). How Common are Fungal Diseases? Available from: http://www.fungalresearchtrust.org [last accessed 16 Dec 2014]
   Google Scholar
• Glavas DM, Islam MT, Hornedo NR, et al. (2004). Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res 21:1192–9
   PubMed Web of Science ®Google Scholar
• Havlickova B, Czaika VA, Friedrich M. (2008). Epidemiological trends in skin mycoses worldwide. Mycoses 51:2–15
   PubMed Web of Science ®Google Scholar
• Hsu JL, Ruoss SJ, Bower ND, et al. (2011). Diagnosing invasive fungal disease in critically ill patients. Crit Rev Microbiol 37:277–312
   PubMed Web of Science ®Google Scholar
• Italia JL, Singh D, Kumar MN. (2009). High performance liquid chromatographic analysis of amphotericin b in rat plasma using naphthol as an internal standard. Anal Chim Acta 634:110–14
   PubMed Web of Science ®Google Scholar
• Jain S, Jain N, Bhadra D, et al. (2005). Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv 2:223–33
   PubMedGoogle Scholar
• Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transferosomes – a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm 29:1013–26
   PubMed Web of Science ®Google Scholar
• Jain S, Tiwary AK, Sapra B, Jain NK. (2007). Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8:E1–9
   PubMed Web of Science ®Google Scholar
• Jain S, Umamaheshwari RB, Bhadra D, Jain NK. (2004). Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Ind J Pharm Sci 66:72–81
   Google Scholar
• Jones DS, Woolfson AD, Brown AF. (1997a). Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 14:450–7
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF. (1997b). Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 151:223–33
   Web of Science ®Google Scholar
• Mall JP, Patel PC, Verma JN. (2009). Simultaneous high performance liquid chromatographic estimation of amphotericin b in dry injection dosage form. Pharma Rev 141–2
   Google Scholar
• Puri R, Jain S. (2012). Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Anticancer Drugs 23:923–34
   PubMed Web of Science ®Google Scholar
• Puri R, Jain S. (2013). Use of biochemical and microscopic techniques to determine enhanced skin permeation of nanovesicles: a mechanistic study. Pharm Nanotechnol 1:213–23
   Google Scholar
• Rautemaa R, Richardson M, Pfaller MA, et al. (2008). Activity of amphotericin B, anidulafungin, capsofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long term azole treatment of chronic mucocutaneous candidiasis. Diagn Microbiol Infect Dis 62:182–5
   PubMed Web of Science ®Google Scholar
• Salerno C, Chiappetta DA, Arechavala A, et al. (2013). Lipid-based microtubes for topical delivery of amphotericin b. Colloids Surfaces B Biointerfaces 107:160–6
   PubMed Web of Science ®Google Scholar
• Sanchez DA, Schairrer D, Tuckman Vernon C, et al. (2014). Amphotericin B releasing nanoparticle topical treatment of Candida species in the setting of burn wound. Nanomed Nanotechnol Biol Med 10:269–77
   PubMed Web of Science ®Google Scholar
• Santos CM, Oliveira RB, Arantes VT, et al. (2012). Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization and in vitro skin permeation studies. Biomed Nanotechnol 8:322–9
   PubMed Web of Science ®Google Scholar
• Sawaya BP, Briggs JP, Schnermann J. (1995). Amphotericin B nephrotoxicity; the adverse consequences of altered membrane properties. J Am Soc Nephrol 6:154–64
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefano D, Campani V, et al. (2013). Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 440:179–87
   PubMed Web of Science ®Google Scholar
• Sharma D, Kaur T, Chadha BS and Manhas RK. (2011). Antimicrobial activity of actinomycetes against multidrug resistant Staphylococcus aureus, e. coliand various other pathogens. Trop J Pharm Res 10:801–8
   Web of Science ®Google Scholar
• Silva RF. (2010). Fungal infections in immunocompromised patients. J Bras Pneumol 36:142–7
   PubMed Web of Science ®Google Scholar
• Singh H, Tiwary AK, Jain S. (2010). Preparation and in vitro in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complexes for topical delivery of colchicines. Yakugaku Zasshi 130:397–407
   PubMed Web of Science ®Google Scholar
• Singh HP, Utreja P, Tiwary AK, Jain S. (2009). Elastic liposomal formulation for sustained delivery of colchicines: in vitro characterization and in vivo evaluation of anti gout activity. AAPS J 2:54–64
   Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18
   PubMed Web of Science ®Google Scholar